Podium to Practice: EHA 2026 – Leukemia: CD7 CAR-T Outcomes in R/R T-ALL/LBL
OR
Studies / Trials Discussed
S110 – LONG-TERM OUTCOMES OF NATURALLY SELECTED CD7 CAR-T THERAPY IN RELAPSED/REFRACTORY T-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA: A COHORT OF 171 PATIENTS
Chair
Explore more from your favourite experts – click their name to access their entire library of content.
Studies/trials discussed:
S110 – LONG-TERM OUTCOMES OF NATURALLY SELECTED CD7 CAR-T THERAPY IN RELAPSED/REFRACTORY T-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA: A COHORT OF 171 PATIENTS
Login to view content
PLease Enter Your Email to view Content
Pre-Video Survey
By continuing to watch the video, you consent to receiving a post-view survey by email.